ESC Late Breaker: REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction
Jean Deepak Bhatt, MD, MPH, FACC
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital; Professor of Medicine, Harvard Medical School; Boston, MA
Interviewer: William E. Boden MD, FACC, FAHA
Professor of Medicine, Boston University School of Medicine, Lecturer in Medicine, Harvard Medical School, Physician Research Lead & Scientific Director, Clinical Trials Network, VA New England Healthcare System; Boston, MA
Zaid I. Almarzooq MBBCh
Fellow in Training, Brigham and Women's Hospital; Boston, MA
REDUCE-IT PRIOR MI showed a large and significant reduction in cardiovascular events, such as heart attack, stroke, and dying from those causes in patients who had sustained a heart attack in the past.